Successful Treatment of Mixed Hepatitis C Genotypes in a Cirrhotic Patient With an All-Oral, Interferon-Free Regimen
Ahmed Sakr, Ayman
Hanifi, Jasmine M.
Valerie Lin, Ming
MetadataShow full item record
CitationAhmed Sakr, Ayman, Jasmine M. Hanifi, and Ming Valerie Lin. 2017. “Successful Treatment of Mixed Hepatitis C Genotypes in a Cirrhotic Patient With an All-Oral, Interferon-Free Regimen.” ACG Case Reports Journal 4 (1): e16. doi:10.14309/crj.2017.16. http://dx.doi.org/10.14309/crj.2017.16.
AbstractMixed hepatitis C virus (HCV) genotype infection is emerging with improved methods of detection. It is commonly seen in hemodialysis patients and intravenous drug users due to repeated HCV exposure and absence of protective immunity, and can contribute to treatment failure. Direct-acting antiviral regimens have been extensively studied in patients with different individual HCV genotypes; however, there are no reported data on their use in patients with mixed HCV genotype. We present a case of mixed HCV genotype 1a and 2 infection in a decompensated cirrhotic patient treated successfully with sofosbuvir, ledipasvir, and ribavirin.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:31731699
- HMS Scholarly Articles